Vaccinia Virus Tropism for Primary Hematolymphoid Cells Is Determined by Restricted Expression of a Unique Virus Receptor
Open Access
- 15 August 2005
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 79 (16), 10397-10407
- https://doi.org/10.1128/jvi.79.16.10397-10407.2005
Abstract
The presumed broad tropism of poxviruses has stymied attempts to identify both the cellular receptor(s) and the viral determinant(s) for binding. Detailed studies of poxvirus binding to and infection of primary human cells have not been conducted. In particular, the determinants of target cell infection and the consequences of infection for cells involved in the generation of antiviral immune responses are incompletely understood. In this report, we show that vaccinia virus (VV) exhibits a more restricted tropism for primary hematolymphoid human cells than has been previously recognized. We demonstrate that vaccinia virus preferentially infects antigen-presenting cells (dendritic cells, monocytes/macrophages, and B cells) and activated T cells, but not resting T cells. The infection of activated T cells is permissive, with active viral replication and production of infectious progeny. Susceptibility to infection is determined by restricted expression of a cellular receptor that is induced de novo upon T-cell activation and can be removed from the cell surface by either trypsin or pronase treatment. The VV receptor expressed on activated T cells displays unique characteristics that distinguish it from the receptor used to infect cell lines in culture. The observed restricted tropism of VV may have significant consequences for the understanding of natural poxvirus infection and immunity and for poxvirus-based vaccine development.Keywords
This publication has 85 references indexed in Scilit:
- Vaccinia Virus Entry into Cells Is Dependent on a Virion Surface Protein Encoded by the A28L GeneJournal of Virology, 2004
- Diagnosis and Management of SmallpoxNew England Journal of Medicine, 2002
- Visualization of Intracellular Movement of Vaccinia Virus Virions Containing a Green Fluorescent Protein-B5R Membrane Protein ChimeraJournal of Virology, 2001
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC functionGene Therapy, 2000
- Vaccinia virus-induced apoptosis in immature B lymphocytes: role of cellular Bcl-2Virus Research, 1998
- HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled ReceptorScience, 1996
- Influence of compounds affecting synthesis, modification and transport of proteins on the expression and release of interleukin‐2 receptorImmunology & Cell Biology, 1995
- Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectorsGene, 1994
- Vaccinia virus and the EGF receptor: A portal for infectivity?Journal of Cellular Biochemistry, 1987